Single Technologies
Pre-clinicalNGS has reached an efficiency plateau with its flat flow cells. Single Technologies introduces 3-D Sequencing™, with a revolutionary three-dimensional sample platform that significantly increases the number of DNA sequences read in parallel. 3-D Sequencing™ seamlessly integrates sequencing with spatial biology, offering unprecedented insights and capabilities. It not only enhances sequencing efficiency but also provides a deeper understanding of biological structures and functions.
About
NGS has reached an efficiency plateau with its flat flow cells. Single Technologies introduces 3-D Sequencing™, with a revolutionary three-dimensional sample platform that significantly increases the number of DNA sequences read in parallel. 3-D Sequencing™ seamlessly integrates sequencing with spatial biology, offering unprecedented insights and capabilities. It not only enhances sequencing efficiency but also provides a deeper understanding of biological structures and functions.
Funding History
2Total raised: $15.2M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile